Emerging role of miR-21 in non-alcoholic fatty liver disease

Role of MicroRNAs in NAFLD/NASH

(2016) Gyongyi Szabo et al.   DIGESTIVE DISEASES AND SCIENCES

Stress-activatedmiR-21/miR-21*in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption

(2016) Nicolas Calo et al.   GUT

Exosomes in liver pathology

(2016) Keisaku Sato et al.   JOURNAL OF HEPATOLOGY

MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway

(2015) Heng Wu et al.   GUT

Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression

(2015) Xavier Loyer et al.   GUT

Expression of Serum Exosomal MicroRNA-21 in Human Hepatocellular Carcinoma

(2014) Hongwei Wang et al.   Biomed Research International

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

(2013) Quentin M. Anstee et al.   Nature Reviews Gastroenterology & Hepatology

Regulation and function of miRNA-21 in health and disease

(2011) Regalla Kumarswamy et al.   RNA Biology

Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression

(2008) Onpan Cheung et al.   HEPATOLOGY

Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes

(2008) Manlio Vinciguerra et al.   HEPATOLOGY